Verona Pharma
Signal active
Organization
Contact Information
Overview
Verona Pharma is a biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory diseases, such as asthma, allergic rhinitis (hay fever), chronic obstructive pulmonary disease (COPD) and cough.
The company creates therapies to address unmet medical requirements in the treatment of respiratory disorders.
Verona Pharma was established in 2005 by Clive Page in London, England.
About
Industries
Biotechnology, Pharmaceutical, Therapeutics
Founded
2005
Employees
51-100
Headquarters locations
Europe
Social
N/A
Profile Resume
Verona Pharma headquartered in Europe, operates in the Biotechnology, Pharmaceutical, Therapeutics sector. The company focuses on Biotechnology and has secured $126.6B in funding across 84 round(s). With a team of 51-100 employees, Verona Pharma is actively contributing to advancements in Biotechnology. Their latest funding round, Post-IPO Equity - Verona Pharma, raised $11.5M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
7
Investors
1
Lead Investors
0
Total Funding Amount
$1507.1M
Details
0
Verona Pharma has raised a total of $1507.1M in funding over 0 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|
Investors
Verona Pharma is funded by 45 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Novo Ventures | - | FUNDING ROUND - Novo Ventures | 65.6M |
| Christopher Thomas Evans | - | FUNDING ROUND - Christopher Thomas Evans | 65.6M |
| Verona Pharma | - | FUNDING ROUND - Verona Pharma | 65.6M |
| Arthurian Life Sciences | - | FUNDING ROUND - Arthurian Life Sciences | 65.6M |
Recent Activity
There is no recent news or activity for this profile.